Alzheimer disease (AD) is a devastating neurodegenerative disorder neuropathologically characterized by abnormal tau accumulation in neurofibrillary tangles (NFTs) and the presence of extracellular amyloid-β plaque deposits.
1 Postmortem studies of AD and more recent neuroimaging studies provide evidence that involvement of the nucleus basalis of Meynert (nbM) may be critical and early in the molecular cascade of events.
2-7 The accumulation of NFTs in the nbM may precede entorhinal cortex and locus coeruleus involvement, making the nbM potentially one of the earliest sites where NFT accumulation occurs.
4,6,8